Literature DB >> 20723244

How do existing HIV-specific instruments measure up? Evaluating the ability of instruments to describe disability experienced by adults living with HIV.

Kelly K O'Brien1, Ahmed M Bayoumi, Carol Strike, Nancy L Young, Kenneth King, Aileen M Davis.   

Abstract

BACKGROUND: Despite the multitude of health challenges faced by adults living with HIV, we know of no HIV-specific instrument developed for the purpose of describing the health-related consequences of HIV, a concept known as disability. In a previous phase of research, adults living with HIV conceptualized disability as symptoms/impairments, difficulties carrying out day-to-day activities, challenges to social inclusion, and uncertainty that may fluctuate on a daily basis and over the course of living with HIV. In this paper, we describe the extent to which existing HIV-specific health-status instruments capture the experience of disability for adults living with HIV.
METHODS: We searched databases from 1980 to 2006 for English language, HIV-specific, self-reported questionnaires consisting of at least two items that were tested for reliability and validity. We then conducted a content analysis to assess how well existing questionnaires describe disability as defined by the Episodic Disability Framework, a framework that conceptualizes this experience from the perspective of adults living with HIV. We matched items of the instruments with categories of the framework to evaluate the extent to which the instruments capture major dimensions of disability in the framework.
RESULTS: We reviewed 4274 abstracts, of which 30 instruments met the inclusion criteria and were retrieved. Of the four major dimensions of disability, symptoms/impairments were included in all 30 instruments, difficulties with day-to-day activities in 16, challenges to social inclusion in 16, and uncertainty in 9. Seven instruments contained at least 1 item from all 4 dimensions of disability (breadth) however, the comprehensiveness with which the dimensions were represented (depth) varied among the instruments.
CONCLUSIONS: In general, symptoms/impairments and difficulties carrying out day-to-day activities were the disability dimensions characterized in greatest depth while uncertainty and challenges to social inclusion were less well represented. Although none of the instruments described the full breadth and depth of disability as conceptualized by the Episodic Disability Framework, they provide a foundation from which to build a measure of disability for adults living with HIV.

Entities:  

Mesh:

Year:  2010        PMID: 20723244      PMCID: PMC2936441          DOI: 10.1186/1477-7525-8-88

Source DB:  PubMed          Journal:  Health Qual Life Outcomes        ISSN: 1477-7525            Impact factor:   3.186


Background

With longer survival, HIV-positive individuals are facing an increasing variety of health-related consequences and symptoms related to HIV infection, associated treatment, and concurrent health conditions [1-11]. Together, these experiences may be conceptualized as disability. We developed a conceptual framework of disability from the perspective of adults living with HIV. In the Episodic Disability Framework, adults living with HIV defined disability as symptoms/impairments, difficulties carrying out day-to-day activities, challenges to social inclusion, and uncertainty that may fluctuate on a daily basis and over the entire course living with HIV [12,13]. Developing programs or interventions to address HIV-related disability mandates the development of a measurement instrument. A patient-reported disability questionnaire might assess the impact of disability for both clinical care and societal level decision making. To date, we know of no instrument developed for the purpose of describing HIV-specific disability. Related instruments, such as functional status and quality of life measures, capture some aspects of disability but may not be comprehensive when considering the range of health-related consequences of HIV [14-19]. Generic disability instruments may not capture population-specific disability experiences [20-23]. The purpose of this research was to evaluate the extent to which HIV-specific health status instruments capture disability experienced by adults living with HIV using the Episodic Disability Framework.

Methods

The Episodic Disability Framework

In a prior phase of research, we developed a conceptual framework of disability from the perspective of adults living with HIV. Specifically, we conducted four focus groups and 15 face-to-face interviews with 38 adults living with HIV, asking individuals to describe their health-related challenges, the physical, social and psychological areas of their life affected, and the impact of these challenges on their overall health. The resulting Episodic Disability Framework conceptualizes disability as multi-dimensional and episodic in nature. The framework is comprised of three main components: 1) dimensions of disability, 2) contextual factors that may exacerbate or alleviate disability, and 3) triggers or life events that may initiate a major or momentous episode for adults living with HIV. Details of this framework were previously published [12,13].

Instruments: Search Strategy and Inclusion Criteria

To identify measures related to disability, we systematically searched the health and psychology literature for instruments that capture elements of the disability experience for adults living with HIV (Figure 1). We searched the following databases for articles published between 1980 and March 2006: MEDLINE, CINAHL, HAPI, EMBASE, and PsycINFO. Subject headings included exploded terms for HIV, HIV infections, health status indicators, quality of life, disability evaluation, behaviour and behaviour mechanisms, activities of daily living, psychiatric status rating scales, data collection, work, socioeconomic factors, signs and symptoms, mental disorders, uncertainty, culture, family, social environment, social isolation, socialization, sociometric techniques, religion, spiritual therapies, and stigma. Slight modifications of this strategy were made for each database. We reviewed abstracts yielded from the search for instruments relevant to disability. If it was unclear from the abstract whether an instrument was applicable, we pulled the full article for review. We also searched reference lists from pertinent articles for potentially relevant instruments.
Figure 1

Overview of Content Analysis Methodology: An overview of the content analysis methodology including the search strategy, abstract review, document analysis of included instruments, validity check, and mapping of items from the instruments according to the category (or code) they represented in the Episodic Disability Framework.

Overview of Content Analysis Methodology: An overview of the content analysis methodology including the search strategy, abstract review, document analysis of included instruments, validity check, and mapping of items from the instruments according to the category (or code) they represented in the Episodic Disability Framework. We included instruments that were published in English, were HIV-specific self-reported questionnaires including at least two items, and had been tested for reliability and validity. We excluded instruments that measured constructs un-related to the four dimensions of disability in the Episodic Disability Framework. When we were uncertain whether to include an instrument or if the instrument was not published within the article, we requested further information from study authors.

Analysis

We analyzed instruments using content analysis, a qualitative method in which pre-defined categories of text are matched against each other and used to compare documents [24]. We compared each instrument against the Episodic Disability Framework [12] We evaluated the instruments against the dimensions of disability in the framework [12] (Figure 2). These dimensions were classified into 10 high-level categories and 72 detailed sub-categories. For example, an item about fatigue received a high-level category of "symptom/impairment" and a sub-category of "fatigue/decreased energy level." We created new sub-categories for instrument items that did not match a pre-identified classification. These new sub-categories represented contextual factors or triggers of disability or items beyond the scope of the framework. See Additional File 1 for a detailed overview of categories.
Figure 2

Episodic Disability Framework: The four dimensions of disability in the Episodic Disability Framework and the number of categories that represent each dimension used for the content analysis.

Episodic Disability Framework: The four dimensions of disability in the Episodic Disability Framework and the number of categories that represent each dimension used for the content analysis. One author categorized all instruments. To assess validity, we assessed agreement between this categorization and that of a community-based author who categorized eight randomly selected instruments. We calculated percent agreement for each instrument by dividing the number of items categorized identically by the total number of items in the instrument. We determined percent agreement for detailed sub-categories, high-level categories, and dimensions of disability. The two raters reconciled any differences by consensus. We mapped items from the instruments onto a matrix according to the category that they represented within the disability framework. An instrument with greater representation of the dimensions of disability in this matrix was determined a priori to possess a greater ability to describe the construct of disability for adults living with HIV. We classified an instrument as having breadth if it contained at least one item from each of the four disability dimensions. We classified an instrument as having depth (for each dimension) if it contained items which corresponded to all pre-specified categories in a given dimension.

Results

We reviewed 4274 abstracts, of which 34 instruments met the inclusion criteria. Instruments were excluded because they were un-related to the Episodic Disability Framework, were measures of adherence to medications, attitudes towards death, internal locus of control, attitudes towards health providers, quality of care, satisfaction, utility indices, disclosure, knowledge about HIV/AIDS, sexual and risk behaviour. Of the 34 instruments identified for inclusion, 30 were retrieved (Table 1). We were unable to retrieve four instruments after three attempts to contact the authors [25-28].
Table 1

Characteristics of Instruments Included in the Content Analysis (n = 30 instruments)

InstrumentAuthorsConstruct Measured^Year DevelopedNumber of Items
Body Image Scale [41]Martinez et alBody Image200512

Assessment of Body Change and Diarrhea Scale (ACBD) [42]Guaraldi et alBody Image200627

HIV Diarrhea Questionnaire [43]Mertz et alDiarrhea199514

HIV-Related Fatigue Scale [44]Barroso & LynnFatigue200056

Health-Related Quality of Life Scale (HIV-QOL) [18]Cleary et alHRQL/QOL199346

AIDS Health Assessment Questionnaire (AIDS-HAQ) [45]Lubeck & FriesHRQL/QOL199455

Functional Assessment of HIV Infection (FAHI) [29,46]Cella & PetermanHRQL/QOL199747

HIV Overview of Problems-Evaluation System (HOPES) [30,47]Ganz & SchagHRQL/QOL1992177

HIV/AIDS Targeted QOL (HAT-QOL) [31,48]Holmes & SheaHRQL/QOL199935

HIV Patient Assessed Report of Status and Experience (HIV-PARSE) [49]Bozzette et alHRQL/QOL1989144

HIV QOL Questionnaire (HIV-QL31) [32]Leplege et alHRQL/QOL199731

Medical Outcomes Survey HIV Health Survey (MOS-HIV) [50,51]Wu et alHRQL/QOL199735

Multidimensional QOL Questionnaire for HIV/AIDS (MQoL-HIV) [33]Avis et alHRQL/QOL199440

World Health Organization QOL HIV Instrument (WHOQOL-HIV) [34,52,53]Fang, O'Connell & WHO HIV/AIDS Quality of Life GroupHRQL/QOL2002120

General Health Self Assessment [54]Lenderking et alHRQL/QOL199750

Living with HIV Scale[55]Holzemer et alHRQL/QOL199832

HIV Cost and Services Utilization Tool [56]Hays et alHRQL/QOL199831

AIDS Clinical Trials Group (ACTG Outcomes SF-21) [57]AIDS Clinical Trials Group Outcomes CommitteeHRQL/QOL199921

Existential Loneliness Questionnaire [58]Mayers et alLoneliness200222

Mental Adjustment to HIV Scale (MAHIVS) [59]Ross et alPsychological Adjustment199440

HIV/AIDS Stress Scale [35]Pakenham & RinaldisStress200229

HIV Stressor Scale [60]Thompson et alStress199625

Physical Symptoms of Illness Scale [27]Nokes et alSymptoms199415

HIV Symptom Index (Justice) [61]Justice et alSymptoms199820

Sign and Symptom Checklist for HIV (SSC-HIV) [62]Holzemer et alSymptoms199926

Riverside Symptom Checklist [63]Burgess et alSymptoms199328

Revised Sign and Symptom Checklist for HIV (SSC-HIVrev) [64]Holzemer et alSymptoms200172

HIV Symptom Index (Whalen) [65]WhalenSymptoms199412

Self-Report Slowness Scale (SRSS) [66]Lopez et alSymptoms199811

Impact of Weight Loss Scale [67]Wagner & RabkinWeight Loss19999

^Construct measured as defined by the author.

HRQL = health-related quality of life; QOL = quality of life

Characteristics of Instruments Included in the Content Analysis (n = 30 instruments) ^Construct measured as defined by the author. HRQL = health-related quality of life; QOL = quality of life

Description of Instruments

The included instruments were developed between 1989 and 2006, 19 of which were published after 1996 when triple drug combination antiretroviral therapy started to be used widely. The number of items in the instruments ranged from nine in the Impact of Weight Loss Scale to 177 in the HIV Overview of Problems-Evaluation System (HOPES). Instruments measured nine different constructs as identified by authors, the majority of which included health-related quality of life/quality of life (HRQL/QOL) (n = 14 instruments), followed by symptoms (n = 7), body image (n = 2), stress (n = 2), fatigue (n = 1), diarrhea (n = 1), loneliness (n = 1), psychological adjustment (n = 1), and impact of weight loss (n = 1) (Table 1).

Document Analysis

There were 108 possible categories to which an item could be assigned for the document analysis, 72 of which represented categories within the four dimensions of disability within the Episodic Disability Framework (Figure 2). An additional 36 categories were generated; 15 of which represented contextual factors (n = 12) and triggers (n = 3) of disability within the framework and 21 that went beyond the scope of the Episodic Disability Framework (see Additional File 1 for a detailed overview of categories). Our validity check demonstrated that agreement for the sub-set of eight instruments varied depending on the level to which the items were categorized. At the most detailed category level (108 possible categories), agreement ranged from 52% in the HIV Quality of Life Questionnaire (HIV-QL31) to 79% in the Functional Assessment of HIV Infection (FAHI) Questionnaire. At the high-level categorization (10 possible categories), agreement ranged from 61% in the HIV-QL31 to 85% in the FAHI Questionnaire. At the dimension of disability level (4 possible categories), we achieved 100% agreement for all eight instruments.

Breadth and Depth of Disability in Instruments

Of the four major dimensions in the Episodic Disability Framework, symptoms/impairments were included in all 30 instruments, difficulties with day-to-day activities in 16, challenges to social inclusion in 16, and uncertainty in 9 (Table 2). Seven instruments demonstrated breadth, that is, they measured some part of all 4 dimensions of disability [29-35]. The number of items in these instruments ranged from 29 (HIV/AIDS Stress Scale) to 177 (HOPES). Authors classified six of the seven scales as HRQL/QOL instruments [29-34], and the other, a stress scale [35] (Table 1).
Table 2

Breadth and Depth of Disability in Instruments

Dimensions of DisabilityBreadth and Depth of Disability
InstrumentSymptoms/Impairment/44 categoriesDifficulties with Day-to-Day Activities/22 categoriesChallenges to Social Inclusion/4 categoriesUncertainty/2 categoriesBreadth (Yes/No)Depth (Yes/No)

Body Image Scale5NoNo

Assessment of Body Change and Diarrhea Scale (ACBD)91NoNo

HIV Diarrhea Questionnaire2NoNo

HIV-Related Fatigue Scale4102NoNo

Health-Related Quality of Life Scale (HIV-QOL)188NoNo

AIDS Health Assessment Questionnaire (AIDS-HAQ)212NoYes

Functional Assessment of HIV Infection (FAHI)12141YesYes

HIV Overview of Problems-Evaluation System (HOPES)251041YesYes

HIV/AIDS Targeted QOL (HAT-QOL)7122YesYes

HIV Patient Assessed Report of Status and Experience (HIV-PARSE)21123NoYes

HIV QOL Questionnaire (HIV-QL-31)9611YesNo

Medical Outcomes Survey HIV Health Survey (MOS-HIV)862NoNo

Multidimensional QOL Questionnaire for HIV/AIDS (MQoL-HIV)8811YesNo

World Health Organization QOL HIV Instrument (WHOQOL-HIV)11631YesYes

General Health Self Assessment1672NoNo

Living with HIV Scale9NoYes

HIV Cost and Services Utilization Tool4102NoNo

AIDS Clinical Trials Group (ACTG Outcomes SF-31)562NoNo

Existential Loneliness Questionnaire41NoNo

Mental Adjustment to HIV Scale (MAHIVS)41NoNo

HIV/AIDS Stress Scale8531YesNo

HIV Stressor Scale12NoNo

Physical Symptoms of Illness Scale12NoNo

HIV Symptom Index (Justice)18NoNo

Sign and Symptom Checklist for HIV (SSC-HIV)13NoNo

Riverside Symptom Checklist18NoNo

Revised Sign and Symptom Checklist for HIV (SSC-HIVrev)27NoYes

HIV Symptom Index (Whalen)12NoNo

Self-Report Slowness Scale (SRSS)19NoNo

Impact of Weight Loss Scale32NoNo

Number of categories of disability represented for each dimension within existing HIV-specific instruments (in alphabetical order based on construct measured). Breadth of disability is defined as an instrument having at least 1 item (or category) represented in each of the four disability dimensions. Depth of disability is defined as having all possible categories represented in a given dimension.

Breadth and Depth of Disability in Instruments Number of categories of disability represented for each dimension within existing HIV-specific instruments (in alphabetical order based on construct measured). Breadth of disability is defined as an instrument having at least 1 item (or category) represented in each of the four disability dimensions. Depth of disability is defined as having all possible categories represented in a given dimension. No instrument captured all of the dimensions of disability comprehensively. The depth in which the dimensions of disability were represented varied among the instruments (Table 2). We highlight eight instruments that most comprehensively represented each of the 4 dimensions of disability. The HOPES instrument most broadly captured symptoms/impairments representing 25 categories, eight of which related to stress, anxiety and depression and emotional challenges. The Revised Sign and Symptom Checklist (SSC-HIVrev) captured 27 categories, of which two addressed stress, anxiety and depression, and emotional challenges. Alternatively, the World Health Organization's Quality of Life HIV Instrument (WHOQOL-HIV) and Living with HIV Scale were the most comprehensive at capturing symptoms/impairments that specifically related to stress, anxiety and depression, and emotional challenges with seven and eight categories, respectively, but possessed fewer categories that represented physical symptoms/impairments (4 categories in the WHOQOL-HIV and 1 category in the Living with HIV Scale). For difficulties with day-to-day activities, the AIDS Health Assessment Questionnaire (AIDS-HAQ) and HIV Patient Assessed Report of Status and Experience (HIV-PARSE) each captured the most depth in this dimension (Table 2). Items captured a range of daily activities, some of which included walking, stair negotiation, activities of daily living, and household chores, all of which were sub-categories in the Episodic Disability Framework. The FAHI and the HOPES represented all categories of challenges to social inclusion. The most common element of social inclusion missing from the other instruments that represented this dimension related to items that captured the challenges related to fulfilling parental roles (Table 2). Uncertainty was less well represented by the instruments. The HIV/AIDS Targeted Quality of Life Scale (HAT-QOL) was the most comprehensive capturing both categories from this dimension. The remaining eight instruments (out of nine) that represented the dimension of uncertainty all captured one category comprised of items that addressed worrying about the future, but did not address the impact uncertainty has on making life decisions (Table 2). Five of the eight comprehensive instruments were developed from 1996 onwards (Table 1). These instruments frequently captured challenges to social inclusion and uncertainty. Four instruments (FAHI, HOPES, HAT-QOL and WHOQOL-HIV) demonstrated both breadth and depth. The HOPES was the only instrument that demonstrated depth in more than one dimension (symptoms/impairments and challenges to social inclusion).

Discussion

No existing HIV-specific health instrument fully captured both the breadth and depth of disability as conceptualized from the perspective of adults living with HIV in the Episodic Disability Framework. Several possible reasons explain this finding. First, these instruments were not developed to measure disability. Accordingly, we did not expect these instruments to fully capture the breadth and depth of disability. Second, disability is a new and emerging construct in the context of HIV. Recent development of the Episodic Disability Framework identified features of disability that were not considered a component of disablement in earlier generic disability frameworks, which explains why uncertainty was less represented among these older measures. Third, many instruments were developed prior to the advent of combination antiretroviral therapy and may not address associated new complexities relating to adverse effects, stigma and disclosure, access issues, and uncertainty about long term outcomes of treatment. Fourth, many of the quality of life instruments we studied were modified from existing generic instruments (e.g. MOS-HIV) or disease-specific instruments in other contexts such as cancer (e.g. HOPES). Such instruments might not capture disablement unique to adults living with HIV, such as issues related to returning to work. Fifth, a greater number of items did not always translate into a greater ability for an instrument to capture disability. For example, while two instruments appeared to possess breadth or depth at capturing dimensions of disability, they were lengthy comprised of more than 140 items (HIV-PARSE and HOPES scale). They demonstrated redundancy within a given category raising questions about feasibility for use of these measures in a clinical setting. Altogether, it is not surprising that existing instruments do not fully address the spectrum of disability for adults living with HIV. Nevertheless, analyses of these questionnaires may serve as a foundation from which to build a disability instrument. A measure of disability that corresponds to dimensions of the Episodic Disability Framework could be developed by pooling items from existing instruments into a new one for adults living with HIV. For example, most items from existing instruments represented symptoms/impairments from the framework. This was not surprising given 16 of the 30 instruments were developed for the purpose of either measuring a combination of symptoms (n = 7) or a specific symptom/impairment (n = 9). Difficulties with day-to-day activities also were well captured by the instruments, commonly represented in instruments originally developed to measure symptoms/impairments and HRQL/QOL. The depth in which these two dimensions were represented provide a comprehensive group of existing items from which to pool together and formulate domains of symptoms/impairments and difficulties with day-to-day activities of a future disability measure. Challenges to social inclusion and uncertainty were less well represented in the instruments. Since the introduction of combination antiretroviral therapy, there has been a shift to consider the broader health-related consequences that adults living with HIV might experience and specifically disability is becoming increasingly important to consider in the context of HIV [36]. Issues related to labour force and income support and worrying about the unpredictable and episodic nature of HIV are examples of types of disability faced by adults living longer with HIV. Accordingly, newer instruments appeared to more closely capture these two disability dimensions in the Episodic Disability Framework and may be a source from which to draw existing items for a new measure. Nevertheless, generation of new items will likely be required to fully capture these dimensions. Results from this content analysis may be used to build a new HIV-specific disability questionnaire. For each of the disability dimensions we may identify instruments that most comprehensively cover a dimension with the least amount of item redundancy. Items from the next most comprehensive instruments may be used to fill any remaining gaps in existing categories. Categories not represented by any existing items would require item generation and could be done in consultation with adults living with HIV. This process may yield a collection of items that comprehensively represent each of the four disability dimensions that could be combined to comprise a new measure of HIV-disability. Once developed, measurement properties of this questionnaire including sensibility, validity, reliability and responsiveness could be assessed with adults living with HIV. Our study has limitations. We excluded generic instruments or instruments developed for use with other illness populations in order to focus on describing disability specifically from the experience of adults living with HIV. We also excluded questionnaires that addressed other components of the Episodic Disability Framework (contextual factors and triggers of disability). However, these instruments may possess content that relates to the dimensions of disability experienced by adults living with HIV. We only cross-validated eight instruments in the document analysis from which low levels of agreement at the sub-category level were initially attained. This was likely due to the large number of categories that an item could be assigned. New questionnaires also have been published since March 2006 and are not captured in this analysis. We performed an updated search from 2006-July 2010 for new HIV-specific health status instruments. Results yielded four instruments that appeared to meet our inclusion criteria [37-40]. Three instruments were HRQL/QOL measures; the Missoula-Vitas Quality-of-Life Index developed to assess quality of life in advanced HIV illness in a palliative care setting [37], the Neurological Quality of Life Questionnaire, a general measure of quality of life in HIV infection [38], and the Chronic Illness Quality of Life Ladder developed to assess quality of life across four time periods (past, present, future, and life without a diagnosis of HIV) [39]. The fourth instrument was a lipodystrophy scale developed to assess the severity of lipodystrophy from the perspective of individuals living with HIV [40]. Similar to the instruments included in our study, none of these instruments were developed to assess the construct of disability. Also, none contained items that represent the dimension of uncertainty.

Conclusions

No existing HIV-specific instrument fully captures the breadth and depth of disability experienced by adults living with HIV as conceptualized by the Episodic Disability Framework. Symptoms/impairments and difficulties carrying out day-to-day activities were characterized in greatest depth among most instruments, whereas challenges to social inclusion and uncertainty were less well represented. Nevertheless, these instruments may serve as a foundation from which to build a future instrument of disability. Future steps include using the Episodic Disability Framework as a foundation from which to establish a collection of items that will formulate a new instrument to describe disability experienced by adults living with HIV. Development of a new HIV disability questionnaire is currently underway.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

KO developed the research question, study design, performed the search strategy, reviewed instruments for inclusion, performed the document analysis, interpreted findings, and drafted the manuscript. This research was completed as part of KO's PhD thesis research study. AB and AD (co-supervisors) and CS and NY (committee members) participated in the development of the research question, study design, oversaw the analysis and helped to draft the manuscript. KK participated in the document analysis, interpretation of findings, and helped to draft the manuscript. All authors have read and approved the final manuscript.

Additional file 1

Detailed Overview of Categories and Sub-Categories (and Codes) for the Document Analysis of Existing HIV-Specific Instruments Click here for file
  58 in total

1.  Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy.

Authors:  M Henderson; F Safa; P Easterbrook; M Hotopf
Journal:  HIV Med       Date:  2005-09       Impact factor: 3.180

2.  Does "asymptomatic" mean without symptoms for those living with HIV infection?

Authors:  Suzanne Willard; William L Holzemer; Dean J Wantland; Yvette P Cuca; Kenn M Kirksey; Carmen J Portillo; Inge B Corless; Marta Rivero-Méndez; María E Rosa; Patrice K Nicholas; Mary Jane Hamilton; Elizabeth Sefcik; Jeanne Kemppainen; Gladys Canaval; Linda Robinson; Shahnaz Moezzi; Sarie Human; John Arudo; Lucille Sanzero Eller; Eli Bunch; Pamela J Dole; Christopher Coleman; Kathleen Nokes; Nancy R Reynolds; Yun-Fang Tsai; Mary Maryland; Joachim Voss; Teri Lindgren
Journal:  AIDS Care       Date:  2009-03

3.  Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument.

Authors:  A H Peterman; D Cella; F Mo; N McCain
Journal:  Qual Life Res       Date:  1997-08       Impact factor: 4.147

4.  Performance of a new, HIV/AIDS-targeted quality of life (HAT-QoL) instrument in asymptomatic seropositive individuals.

Authors:  W C Holmes; J A Shea
Journal:  Qual Life Res       Date:  1997-08       Impact factor: 4.147

5.  Assessment of quality of life in early stage HIV-infected persons: data from the AIDS Time-oriented Health Outcome Study (ATHOS).

Authors:  D P Lubeck; J F Fries
Journal:  Qual Life Res       Date:  1997-08       Impact factor: 4.147

6.  Validation of a new measure of diarrhea.

Authors:  H R Mertz; C K Beck; W Dixon; M A Esquivel; R D Hays; M F Shapiro
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

7.  ISSQoL: a new questionnaire for evaluating the quality of life of people living with HIV in the HAART era.

Authors:  R Bucciardini; R Murri; M Guarinieri; F Starace; M Martini; A Vatrella; L Cafaro; M Fantoni; R Grisetti; A d'Arminio Monforte; V Fragola; R Arcieri; C Del Borgo; A Tramarin; M Massella; D Lorenzetti; S Vella
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

Review 8.  Stigma, HIV and AIDS: an exploration and elaboration of a stigma trajectory.

Authors:  A A Alonzo; N R Reynolds
Journal:  Soc Sci Med       Date:  1995-08       Impact factor: 4.634

9.  Validation of the World Health Organization quality of life instrument in patients with HIV infection.

Authors:  C T Fang; P C Hsiung; C F Yu; M Y Chen; J D Wang
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 3.440

10.  Impairments, activity limitations and participation restrictions: prevalence and associations among persons living with HIV/AIDS in British Columbia.

Authors:  Melanie Rusch; Stephanie Nixon; Arn Schilder; Paula Braitstein; Keith Chan; Robert S Hogg
Journal:  Health Qual Life Outcomes       Date:  2004-09-06       Impact factor: 3.186

View more
  7 in total

Review 1.  A Review of HIV-Specific Patient-Reported Outcome Measures.

Authors:  Kim Engler; David Lessard; Bertrand Lebouché
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

2.  Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework.

Authors:  Mark J Siedner
Journal:  J Aging Health       Date:  2017-08-23

3.  A comparison of quality of life between HIV positive and negative diamond miners in South Africa.

Authors:  Jeff Gow; Gavin George; Kaymarlin Govender
Journal:  SAHARA J       Date:  2013

4.  A mixed methods approach to adapting and evaluating the functional assessment of HIV infection (FAHI), Swahili version, for use with low literacy populations.

Authors:  Moses K Nyongesa; Antipa Sigilai; Amin S Hassan; Janet Thoya; Rachael Odhiambo; Fons J R Van de Vijver; Charles R J C Newton; Amina Abubakar
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

5.  Development and validation of PozQoL: a scale to assess quality of life of PLHIV.

Authors:  Graham Brown; Gosia Mikołajczak; Anthony Lyons; Jennifer Power; Fraser Drummond; Aaron Cogle; Brent Allan; Craig Cooper; Simon O'Connor
Journal:  BMC Public Health       Date:  2018-04-20       Impact factor: 3.295

6.  Reliability and Validity of the HIV Disability Questionnaire (HDQ) with Adults Living with HIV in the United States.

Authors:  Kelly Kathleen O'Brien; David Kietrys; Mary Lou Galantino; James Scott Parrott; Tracy Davis; Quang Tran; Rachel Aubry; Patricia Solomon
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

7.  Reliability and validity of a new HIV-specific questionnaire with adults living with HIV in Canada and Ireland: the HIV Disability Questionnaire (HDQ).

Authors:  Kelly K O'Brien; Patricia Solomon; Colm Bergin; Siobhán O'Dea; Paul Stratford; Nkem Iku; Ahmed M Bayoumi
Journal:  Health Qual Life Outcomes       Date:  2015-08-12       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.